There are nearly 10,000 STERRAD Sterilization machines in about 6,300 US hospitals, and the reprocessing times vary from 55 minutes, to 28 minutes, and 24 minutes, depending on which particular STERRAD machine is being used.
A second emergency use authorization (EUA) that officials hope will replenish supplies of desperately needed N95 masks has been issued by the US Food and Drug Administration (FDA). The FDA made headlines last Friday with is first EUA, granted to STERIS Corporation whose sterilization process can decontaminate about 750,000 N95 masks a day. Yesterday, the FDA granted the EUA to Advanced Sterilization Products (ASP), which could lead to the sterilization of as many as 4 million N95 respirators a day.
According to the FDA, ASP’s STERRAD Sterilization Cycles uses vaporized hydrogen peroxide gas plasma sterilization. The system is already in place. There are nearly 10,000 STERRAD Sterilization machines in about 6,300 US hospitals, and the reprocessing times vary from 55 minutes, to 28 minutes, and 24 minutes, depending on which particular STERRAD machine is being used. Each can reprocess about 480 respirators a day.
The EUAs take their cue from research by Duke University investigators. Scott Alderman, associate director of Duke’s regional biocontainment laboratory, said in a press release on March 26: “This is a decontamination technology and method we’ve used for years in our biocontainment laboratory.
Matthew Stiegel, Ph.D., director of Duke’s occupational and environmental safety office, added: “We had never considered needing it for something like face masks. But we’ve now proven that it works and will begin using the technology immediately in all three Duke Health hospitals.”
It’s been known that hydrogen peroxide can decontaminate N95 masks since 2016, but that was never followed by widespread adaptation, according to Duke officials. The earlier studies did not include fit testing after cleaning, which would determine if the masks worked for different individuals, an important efficacy element. Duke research tested for that.
“The decontamination process requires specialized equipment that vaporizes the hydrogen peroxide, and a closed facility where the masks can be exposed to the vapor,” Duke said in the press release. “No toxic byproducts result, because hydrogen peroxide breaks down to water.”
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.